REED ELIZABETH E — SEC Form 4 filings
SEC reporting owner CIK 1283303. 17 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-01-25 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 17 filings — 208,940 shares, $7,893,010 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 37,500 shares @ $41.07 ($1,540,125) in Travere Therapeutics, Inc., filed 2026-04-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | 17 | — | 28 legs · 208,940 sh · $7,893,010 | 35 |
Form 4 filings — REED ELIZABETH E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 37,500 @ $15.46 · Sale (S): 21,926 @ $62.03 · Sale (S): 13,874 @ $62.63 · Sale (S): 1,400 @ $63.69 · Sale (S): 300 @ $65.31 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 20,000 @ $17.96 · Sale (S): 20,000 @ $45 · Option exercise (M): 4,250 @ $0 · Sale (S): 2,174 @ $46.65 · Sale (S): 2,076 @ $43.95 · Option exercise (M): 20,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-15 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 14,000 @ $0 · Option exercise (M): 10,000 @ $19.08 · Option exercise (M): 20,000 @ $17.96 · Option exercise (M): 7,500 @ $15.46 · Sale (S): 37,500 @ $41.07 · Sale (S): 7,215 @ $41.93 · +5 more | EDGAR |
| 2026-04-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 10,000 @ $15.46 · Sale (S): 10,000 @ $30 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 10,000 @ $19.08 · Sale (S): 10,000 @ $28.09 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 10,000 @ $19.08 · Sale (S): 5,679 @ $27.50 · Sale (S): 4,321 @ $28.26 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,485 @ $32.07 · Sale (S): 509 @ $32.74 | EDGAR |
| 2026-02-03 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 25,110 @ $0 · Sale (S): 7,175 @ $32.12 · Grant/award (A): 66,960 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 10,000 @ $19.08 · Sale (S): 10,000 @ $27.34 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 10,000 @ $19.08 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 4,920 · Sale (S): 4,920 @ $21.05 · Option exercise (M): 4,920 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 8,000 · Sale (S): 8,000 @ $23.53 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 21,500 @ $0 · Sale (S): 8,951 @ $19.78 · Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,437 @ $19.46 | EDGAR |
| 2024-09-09 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 6,750 @ $0 · Sale (S): 4,387 @ $11.52 | EDGAR |
| 2024-02-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 25,000 @ $0 · Sale (S): 2,174 @ $8.53 · Sale (S): 2,590 @ $8.86 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,062 @ $8.96 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1283303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →